mailto:?subject=Link to ANA content&body=Link%20to%20ANA%20content%0A%0ATitle.....%3A%20FDA%20Review%20of%20Pharma%20Ads%20Could%20Reshape%20D2C%20Marketing%0ALink......%3A%20http%3A%2F%2Fwww.ana.net%2Fmagazines%2Fshow%2Fid%2Fnews-2026-07-17-policy-brief%0A%0AThe%20FDA%20is%20proposing%20a%20rule%20that%20could%20force%20prescription%20drug%20TV%20and%20radio%20ads%20to%20include%20all%20risk%20and%20safety%20information%20within%20the%20spot%20itself.%20The%20change%20may%20reshape%20pharma%20D2C%20campaign%20strategy%2C%20creative%20development%2C%20and%20media%20buying%20across%20a%20market%20that%20spent%20nearly%20%246%20billion%20on%20national%20TV%20drug%20ads%20in%202025.%0A%0A%0A------------------------------------------------------%0AClick%20on%20the%20link%20above%20to%20visit%20this%20page.%20%20If%20the%20link%20is%20not%20clickable%20in%20your%20email%20client%2C%20copy%20and%20paste%20it%20into%20a%20web%20browser.%0A